Retooling drug development with next-generation machine learning, Owkin nabs $11M

Relatively small and dispersed data sets and privacy issues represent two challenges in applying machine learning in drug development. Enter predictive analytics firm Owkin, which aims to overcome them through transfer and federated learning. It has secured $11 million in series A to do just…